Revisions to USP 31–NF 26, Second Supplement

Revisions to USP 31–NF 26, Second Supplement (published May 2008) Published April 2008 <a href="file:///USPNF/revisions/usp31nf26secondSupplement01.html" target="_blank">General Chapters </a>Monographs:A–C D–N <a href="file:///USPNF/revisions/usp31nf26secondSupplement04.html" target="_blank">O–S </a><a href="file:///USPNF/revisions/usp31nf26secondSupplement05.html" target="_blank">T–Z </a><ul style="display: flex;"><li style="flex:1">Monograph Title </li><li style="flex:1">Section Head </li><li style="flex:1">Scientific Liaison </li></ul>DANTROLENE SODIUM CAPSULES PF 33(4) Pg. 645 Dissolution <711> DEHYDROACETIC ACID PF 33(4) Pg. 703 Title DEHYDROACETIC ACID PF 33(4) Pg. 703 Chemical Info DEHYDROACETIC ACID PF 33(4) Pg. 703 Definition DEHYDROACETIC ACID PF 33(4) Pg. 703 Packaging and storage USP Reference standards <11> Identification DEHYDROACETIC ACID PF 33(4) Pg. 703 DEHYDROACETIC ACID PF 33(4) Pg. 703 DEHYDROACETIC ACID PF 33(4) Pg. 703 Heavy Metals, Method II <231> Loss on drying <731> Melting range, Class I <741> Residue on ignition <281> Assay DEHYDROACETIC ACID PF 33(4) Pg. 703 DEHYDROACETIC ACID PF 33(4) Pg. 703 DEHYDROACETIC ACID PF 33(4) Pg. 703 DEHYDROACETIC ACID PF 33(4) Pg. 703 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Title 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Definition 784 file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Packaging and storage 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Labeling 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. USP Reference stadards 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Identification 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Uniformity of dosage units 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Loss on drying 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Related compounds 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 32(3) Pg. Assay 784 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Title 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Definition 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Labeling 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Loss on drying <731> 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Acid-neutralizing capacity <301> 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Related compounds 903 DIDANOSINE TABLETS FOR ORAL SUSPENSION PF 33(5) Pg. Assay file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] 903 DILTIAZEM HYDROCHLORIDE PF 33(5) Pg. 907 Definition DIMENHYDRINATE INJECTION PF 33(5) Pg. 907 USP Reference standards <11> Identification DIMENHYDRINATE INJECTION PF 33(5) Pg. 907 DIMENHYDRINATE PF 33(5) Pg. 907 Identification DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 Title DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 Definition DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 Packaging and storage Labeling DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 USP Reference standards <11> Identification DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 Bacterial endotoxins <85> Sterility <71> pH <791> DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 Other requirements Assay DINOPROST TROMETHAMINE INJECTION PF 33(5) Pg. 908 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Title ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Definition ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Packaging and storage Labeling ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM USP Reference standards file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Identification A, B, C Clarity ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Color ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 pH ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Benzyl alcohol content Free sulfate content Anti-factor IIa activity Anti-factor Xa to anti-factor IIa ratio ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Other requirements - Sterility Tests <71> ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 Other requirements Assay (anti-factor Xa activity) Bacterial endotoxins Definition ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 31(3) Pg. 761 ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 Appearance of solution (Clarity and degree of color of liquids) ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 Benzyl alcohol content (if present) Bacterial endotoxins <85> Free sulfate content ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 ENOXAPARIN SODIUM INJECTION PF 33(1) Pg. 58 Assay (anti-factor Xa activity) Title ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Chemical structure file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 CAS number ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Definition ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Packaging and storage USP Reference standards Identification A, B, C, D, E Appearance of solution Specific absorbance pH ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Loss on drying ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Nitrogen content ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Heavy metals ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Sodium content ENOXAPARIN SODIUM PF 29(6) Pg. 1876 Molar ratio of sulfate to carboxylate Benzyl alcohol content Anti-factor IIa activity Assay (anti-factor Xa activity) Bacterial endotoxins Definition ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 29(6) Pg. 1876 ENOXAPARIN SODIUM PF 33(1) Pg. 52 ENOXAPARIN SODIUM PF 33(1) Pg. 52 USP Reference standards <11> Identification ENOXAPARIN SODIUM PF 33(1) file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Pg. 52 ENOXAPARIN SODIUM PF 33(1) Appearance of solution (Clarity and <ul style="display: flex;"><li style="flex:1">Pg. 52 </li><li style="flex:1">degree of color of liquids) </li></ul>ENOXAPARIN SODIUM PF 33(1) Pg. 52 pH <791> ENOXAPARIN SODIUM PF 33(1) Molar ratio of sulfate to carboxylate <ul style="display: flex;"><li style="flex:1">Pg. 52 </li><li style="flex:1">(see Chromatography <621>) </li></ul>ENOXAPARIN SODIUM PF 33(1) Pg. 52 Benzyl alcohol content ENOXAPARIN SODIUM PF 33(1) Pg. 52 Anti-factor IIa activity ENOXAPARIN SODIUM PF 33(1) Pg. 52 Assay (anti-factor Xa activity) ESTRADIOL AND NORETHINDRONE ACETATE TABLETS PF 31(5) Pg. 1364 Dissolution Dissolution ESTRADIOL AND NORETHINDRONE ACETATE TABLETS PF 33(2) Pg. 220 ETHINYL ESTRADIOL TABLETS PF 31(4) Pg. 1067 Disintegration <ul style="display: flex;"><li style="flex:1">Assay </li><li style="flex:1">ETHIONAMIDE PF 33(4) Pg. 648 </li></ul>FAMOTIDINE TABLETS PF 33(4) Pg. 649 Dissolution <711> FORMALDEHYDE SOLUTION PF 33(4) Pg. 650 Definition FORMALDEHYDE SOLUTION PF 33(4) Pg. 650 Labeling FORMALDEHYDE SOLUTION PF 33(4) Pg. 650 Content of methanol Assay FORMALDEHYDE SOLUTION PF 33(4) Pg. 650 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 Title Chemical Info Definition Packaging and storage USP Reference standards <11> Identification Specific rotation <781S> file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 FULVESTRANT PF 33(5) Pg. 909 Water, Method Ic <921> Residue on ignition <281> Related compounds Diastereoisomer ratio Assay GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 Microbial limits Title GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 Molecular weight Packaging and storage Identification A, B, C Specific rotation Loss on drying GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 Residue on ignition Heavy metals GAMMA CYCLODEXTRIN PF 31(3) Pg. 812 GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 Chemical Info GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 Definition GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 USP Reference standards <11> Color and clarity of solution Related compounds Reducing substances Assay GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 GAMMA CYCLODEXTRIN PF 33(4) Pg. 707 GLUCOSAMINE <ul style="display: flex;"><li style="flex:1">HYDROCHLORIDE PF 33(4) Pg. </li><li style="flex:1">Specific rotation <781S> </li></ul>file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] 691 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Identification Pg. 692 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Specific rotation <781S> Pg. 692 GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Residue on ignition <281> Pg. 692 GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. Identification 692 GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. Specific rotation <781S> 692 GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. Residue on ignition <281> 692 HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLETS PF Labeling 33(4) Pg. 654 HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLETS PF Dissolution <711> 33(4) Pg. 654 HYDROPHOBIC COLLOIDAL Title SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Chemical Info SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Definition SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Packaging and storage SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Identification SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Limit of chloride SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Limit of lead SILICA PF 33(5) Pg. 976 HYDROPHOBIC COLLOIDAL Water-dispersible substances SILICA PF 33(5) Pg. 976 file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] HYDROPHOBIC COLLOIDAL SILICA PF 33(5) Pg. 976 Loss on ignition <733> Assay HYDROPHOBIC COLLOIDAL SILICA PF 33(5) Pg. 976 HYOSCYAMINE SULFATE PF 33(4) Pg. 659 Specific rotation <781S> INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 INOSITOL PF 33(4) Pg. 711 ISOSORBIDE MONONITRATE Title Chemical Info Definition Packaging and storage USP Reference standards <11> Clarity of solution Color of solution Identification Conductivity Water, Method I <921> Barium Limit of lead Related compounds Assay EXTENDED-RELEASE TABLETS Dissolution <711> PF 33(4) Pg. 659 ISOTRETINOIN CAPSULES PF Dissolution <711> 33(4) Pg. 666 IVERMECTIN AND CLORSULON Title INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Definition INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Packaging and storage INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON Labeling INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 USP Reference standards <11> Identification IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 Bacterial endotoxins <85> Sterility <71> IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 Other requirements Assay for ivermectin Assay for clorsulon Title IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 IVERMECTIN AND CLORSULON INJECTION PF 33(5) Pg. 921 IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN INJECTION PF 33(5) Pg. 913 Definition IVERMECTIN INJECTION PF 33(5) Pg. 913 Packaging and storage Labeling IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN INJECTION PF 33(5) Pg. 913 USP Reference standards <11> Identification IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN INJECTION PF 33(5) Pg. 913 Bacterial endotoxins <85> Sterility <71> IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN INJECTION PF 33(5) Pg. 913 Chromatographic purity Other requirements Assay IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN INJECTION PF 33(5) Pg. 913 IVERMECTIN PASTE PF 33(5) Pg. 914 Title IVERMECTIN PASTE PF 33(5) Pg. 914 Definition IVERMECTIN PASTE PF 33(5) Pg. 914 Packaging and storage Labeling IVERMECTIN PASTE PF 33(5) Pg. 914 file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] IVERMECTIN PASTE PF 33(5) Pg. 914 USP Reference standards <11> Identification IVERMECTIN PASTE PF 33(5) Pg. 914 IVERMECTIN PASTE PF 33(5) Pg. 914 Chromatographic purity IVERMECTIN PASTE PF 33(5) Pg. 914 Assay <ul style="display: flex;"><li style="flex:1">IVERMECTIN PF 33(5) Pg. 912 </li><li style="flex:1">Definition </li></ul>Title IVERMECTIN TABLETS PF 33(5) Pg. 918 IVERMECTIN TABLETS PF 33(5) Pg. 918 Definition IVERMECTIN TABLETS PF 33(5) Pg. 918 Packaging and storage USP Reference standards <11> Identification IVERMECTIN TABLETS PF 33(5) Pg. 918 IVERMECTIN TABLETS PF 33(5) Pg. 918 IVERMECTIN TABLETS PF 33(5) Pg. 918 Uniformity of dosage units <905> Limit of 8a-oxo-H2B1a Assay IVERMECTIN TABLETS PF 33(5) Pg. 918 IVERMECTIN TABLETS PF 33(5) Pg. 918 IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 Title IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 Definition IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 Packaging and storage Labeling IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 USP Reference standards <11> Identification IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 IVERMECTIN TOPICAL SOLUTION PF 33(5) Pg. 916 Chromatographic purity Assay IVERMECTIN TOPICAL file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] SOLUTION PF 33(5) Pg. 916 LIGHT MINERAL OIL PF 33(5) Pg. 972 Definition LIGHT MINERAL OIL PF 33(5) Pg. 972 Packaging and storage Labeling LIGHT MINERAL OIL PF 33(5) Pg. 972 LIGHT MINERAL OIL PF 33(5) Pg. 972 USP Reference standards <11> Identification LIGHT MINERAL OIL PF 33(5) Pg. 972 LIGHT MINERAL OIL PF 33(5) Pg. 972 Viscosity <911> Acidity,Readily carbonizable LIGHT MINERAL OIL PF 33(5) Pg. substances, Limit of polycyclic <ul style="display: flex;"><li style="flex:1">972 </li><li style="flex:1">aromatic hydrocarbons, Limit of </li></ul>sulfur compounds, and Solid paraffin MAGALDRATE AND SIMETHICONE ORAL SUSPENSION PF 33(5) Pg. 923 Defoaming activity Defoaming activity Defoaming activity Assay MAGALDRATE AND SIMETHICONE TABLETS PF 33(5) Pg. 923 MAGALDRATE AND SIMETHICONE TABLETS PF 33(5) Pg. 923 MEFLOQUINE HYDROCHLORIDE PF 33(4) Pg. 667 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 Chemical Info Definition Packaging and storage Labeling USP Reference standards <11> Identification Neutrality Acidity Readily carbonizable substances Limit of polycyclic aromatic hydrocarbons MINERAL OIL PF 33(5) Pg. 962 file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] MINERAL OIL PF 33(5) Pg. 962 MINERAL OIL PF 33(5) Pg. 962 Limit of sulfur compounds Viscosity MINERAL OIL, RECTAL PF 33(5) Pg. 964 Packaging and storage USP Reference standards <11> Identification MINERAL OIL, RECTAL PF 33(5) Pg. 964 MINERAL OIL, RECTAL PF 33(5) Pg. 964 MINERAL OIL, RECTAL PF 33(5) Pg. 964 Viscosity MINERAL OIL, RECTAL PF 33(5) Pg. 964 Neutrality MINERAL OIL, RECTAL PF 33(5) Pg. 964 Acidity MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 Title MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 Chemical Info MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 Definition MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 Packaging and storage USP Reference standards <11> Identification MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 Melting range, Class Ia <741> Loss on drying <731> Residue on ignition <281> Heavy metals, Method II <231> Related compounds Assay MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 MYCOPHENOLATE MOFETIL PF 33(5) Pg. 924 NAPHAZOLINE HYDROCHLORIDE file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM] Assay OPHTHALMIC SOLUTION PF 33(5) Pg. 926 NICOTINE TRANSDERMAL SYSTEM PF 33(5) Pg. 927 Drug release <724> Assay NICOTINE TRANSDERMAL SYSTEM PF 33(5) Pg. 927 NORETHINDRONE TABLETS PF 32(6) Pg. 1736 Labeling NORETHINDRONE TABLETS PF 32(6) Pg. 1736 Disintegration <701> Dissolution <711> NORETHINDRONE TABLETS PF 33(3) Pg. 432 <a href="file:///USPNF/revisions/usp31nf26secondSupplement01.html" target="_blank">General Chapters </a>Monographs:A–C D–N <a href="file:///USPNF/revisions/usp31nf26secondSupplement04.html" target="_blank">O–S </a><a href="file:///USPNF/revisions/usp31nf26secondSupplement05.html" target="_blank">T–Z </a>file:///C|/Documents%20and%20Settings/rwt/Desktop/revisions/usp31nf26secondSupplement03.html[4/26/2011 1:18:07 PM]

Revisions to USP 31–NF 26, Second Supplement

Details

Download

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

Support